Skip to content
GenoLensGenoLens

SOD1

Chr 21q22.11

superoxide dismutase 1

Aliases:
IPOA
MANE:
ENST00000270142.11

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Adult onset neurodegenerative disorder

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Amyotrophic lateral sclerosis/motor neuron disease

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Childhood onset hereditary spastic paraplegia

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Hereditary neuropathy or pain disorder

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Monogenic hearing loss

Disease associations (Open Targets)

  • amyotrophic lateral sclerosis

    0.88
  • spastic tetraplegia and axial hypotonia, progressive

    0.69
  • motor neuron disorder

    0.59
  • neurodegenerative disease

    0.55
  • familial amyotrophic lateral sclerosis

    0.50
  • sporadic amyotrophic lateral sclerosis

    0.50
  • frontotemporal dementia with motor neuron disease

    0.36
  • Limb muscle weakness

    0.34
  • Atrophy/Degeneration affecting the central nervous system

    0.31
  • skull disorder

    0.27

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Superoxide dismutase [Cu-Zn]

Destroys radicals which are normally produced within the cells and which are toxic to biological systems (PubMed:18948262, PubMed:24140062). Catalyzes the oxidation of hydrogen sulfide (H2S) to sulfate, playing an important role in detoxifying H2S and limiting the accumulation of reactive sulfur species (RSS) such as persulfides and polysulfides (PubMed:36630448)

Curated MONDO disease pages that list SOD1 among their top associated genes.

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.